Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Phosphoinositide-lipid signaling in neuronal mitochondrial biogenesis

Descripción del proyecto

Visión molecular de la biogénesis mitocondrial en las neuronas

Las mitocondrias constituyen el centro neurálgico de las células y proporcionan la mayor parte de la energía y los metabolitos necesarios. La alteración de la función mitocondrial está vinculada a enfermedades neurodegenerativas y neuropsiquiátricas. El equipo del proyecto MitoPIP, financiado por el Consejo Europeo de Investigación, se centrará en comprender la biogénesis mitocondrial en las neuronas. La labor consistirá en determinar el papel de los lípidos y cómo pueden influir sobre la correcta localización mitocondrial en las neuronas, un aspecto fundamental para el mantenimiento de las conexiones funcionales. Los investigadores comprobarán si la modulación de los lípidos en las neuronas mediante fármacos específicos puede restablecer la función mitocondrial alterada, con lo que se ofrecería tratamiento para enfermedades neurodegenerativas y neuropsiquiátricas.

Objetivo

Mitochondrial dysfunction leads to several neurodegenerative diseases and is implicated in neuropsychiatric disorders, yet our understanding of how mitochondrial biogenesis is tailored to neurons is very limited. My identification of a role for the phosphatidylinositol-(4,5)bisphosphate (PIP2) phosphatase SYNJ2 in local mitochondrial biogenesis connects phospholipid signalling with mitochondrial maintenance and mitophagy in axons. My lab is already utilizing advanced imaging methods to study RNA transport and local mitochondrial biogenesis. Recent advances in local lipid perturbations now make it possible to also identify lipid-mediated regulatory mechanisms of mitochondrial biogenesis.
This project spans all the way from mitochondrial biochemistry and signaling mechanisms to neuronal cell biology and local translation, culminating in how the molecular effects alter mouse physiology and behavior. We have preliminary evidence that PIP lipids are involved in the regulation of RNA tethering and local translation. This occurs at mitochondria-endosome contacts, which are enriched in PIP lipids. Likewise, contact sites between mitochondria and late-Golgi or lysosomes provide PIP lipids during mitochondrial fission, yet both organelles are rare in axons. SYNJ2a, which is a neuron-enriched splice variant, could underlie the special morphology of axonal mitochondria and contribute to axonal mitochondrial fission. Finally, PIP altering drugs are used for the treatment of mood disorders, and mitochondria and mitophagy have come recently into the spotlight for their role in neuropsychiatric disorders. Alteration of local mitochondrial biogenesis via altered PIP levels may provide a mechanistic link between mitochondria and mood disorders. MitoPIP will be of significance to patients with neurodegenerative and neuropsychiatric diseases, as it will advance our understanding of whether restoration of mitochondrial function in axons can be achieved through regulation of lipids.

Institución de acogida

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Aportación neta de la UEn
€ 1 497 500,00
Dirección
HOFGARTENSTRASSE 8
80539 Munchen
Alemania

Ver en el mapa

Región
Bayern Oberbayern München, Kreisfreie Stadt
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 1 497 500,00

Beneficiarios (1)